BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

Core Insights - Bio-Techne Corporation will showcase its latest research products at the AMP 2024 Annual Meeting & Expo, focusing on breast cancer monitoring and carrier screening [1][2] - The company aims to highlight new products that enhance data collection and analysis in molecular diagnostics [2] Product Presentations - The QuantideX® qPCR ESR1 exoMutation Kit will be featured, demonstrating analytical sensitivity of ≤0.1% across 11 ESR1 mutations [3] - The AmplideX® Nanopore Carrier Plus Kit will be presented, which combines PCR chemistry with Oxford Nanopore® technology to identify complex genetic alterations [4] Workshops and Discussions - A session on LDT compliance will address the challenges posed by the FDA's laboratory-developed test rule, discussing various tactical approaches for compliance [5] - Asuragen will host multiple activities and presentations throughout the event, including poster sessions on liquid biopsy surveillance and complex variant genotyping [6][7] Company Overview - Bio-Techne Corporation generated approximately $1.2 billion in net sales in fiscal 2024 and employs over 3,100 people globally [9]